Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2026-07-19 @ 5:25 AM
Study NCT ID:
NCT01725204
Status:
COMPLETED
Last Update Posted:
2017-09-25
First Post:
2012-11-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Pegylated IFN-alpha 2B Added to Dasatinib in Newly Diagnosed Chronic Phase Myeloid Leukemia
Sponsor:
Norwegian University of Science and Technology
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NordCML007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None